Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Jun 23, 2026 (4 months ago)

Glucagon Emergency Kit for Low Blood Sugar

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.

Cause type: Stability / shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency. All stability / shelf life recalls.

What was recalled

Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-311-01

Affected NDC 70748-0311-01

Compare with the code on your package — it is the most precise check available.

Drug: Glucagon

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Glucagon
NDC 70748-0311
Kit Lupin Pharmaceuticals, Inc. Rx
Recalling firm
Lupin Pharmaceuticals Inc.
NDC code
70748-311-01
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0723-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Glucagon recalls

See all
Class II · Moderate risk

Glucagen (glucagon)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0597-0053-45 D-1038-2022
Class II · Moderate risk

GlucaGen (glucagon)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0597-0260-10 D-1017-2022
Class I · High risk

GlucaGen HypoKit

Defective delivery system: detached needles on the syringe in the kit.

Terminated Packaging defect Novo Nordisk Inc NDC 0169-7065-15 D-0217-2017

Other recalls by Lupin Pharmaceuticals Inc.

All 2026 recalls
Class II · Moderate risk

Ganirelix Acetate Injection

Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.

Ongoing Impurity / degradation Lupin Pharmaceuticals Inc. NDC 70748-274-01 D-0220-2026